Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Published:2004-04-12 Issue:32 Volume:23 Page:5513-5522
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Knight-Krajewski Selena,Welsh Catherine F,Liu YunQi,Lyons Leah S,Faysal Joanne M,Yang Eddy S,Burnstein Kerry L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1207708.pdf

Reference65 articles.

1. Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M and Kosma VM . (1999). Prostate, 39, 8–15.

2. Adnane J, Bizouarn FA, Qian Y, Hamilton AD and Sebti SM . (1998). Mol. Cell. Biol., 18, 6962–6970.

3. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW and Scher HI . (1999). J. Natl. Cancer Inst., 91, 1869–1876.

4. Aktories K and Just I . (1995). Trends Cell Biol., 5, 441–443.

5. Auer KL, Park J-S, Seth P, Coffey RJ, Darlington G, Abo A, McMahon M, DePinho RA, Fisher PB and Dent P . (1998). Biochem. J., 336, 551–560.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins and prostate cancer—hype or hope? The biological perspective;Prostate Cancer and Prostatic Diseases;2022-06-29

2. Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival;Molecular Cancer Therapeutics;2021-03-15

3. P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer;Cancers;2020-02-19

4. MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer;Cancer Drug Resistance;2020

5. Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models;The Prostate;2018-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3